PLANT PATHOGEN RESISTANCE GENES AND USES THEREOF

Abstract: The Arabidopsis RPP5 gene has been cloned and its sequence provided, along with the encoded amino acid sequence. DNA encoding the polypeptide, and alleles, mutants and derivatives thereof, may be introduced into plant cells and the encoded polypeptide expressed, conferring pathogen resistance on plants comprising such cells and descendants thereof. The RPP5 sequence comprises leucine rich repeats and the presence of such repeats enables identification of other plant pathogen resistance genes. Homologies between RPP5 and other pathogen resistance genes reveal motifs useful in identification of other pathogen resistance genes.

Description: PLANT PATHOGEN RESISTANCE GENES AND USES THEREOF The present invention relates to pathogen resistance in plants and more particularly to the identification and use of pathogen resistance genes. It is based on cloning of the Arabidopsis RPP5 gene. Plants are constantly challenged by potentially pathogenic microorganisms. Crop plants are particularly vulnerable, because they are usually grown as genetically uniform monocultures; when disease strikes, losses can be severe. However, most plants are resistant to most plant pathogens. To defend themselves, plants have evolved an array of both preexisting and inducible defences. Pathogens must specialize to circumvent the defence mechanisms of the host, especially those biotrophic pathogens that derive their nutrition from an intimate association with living plant cells. If the pathogen can cause disease, the interaction is said to be compatible, but if the plant is resistant, the interaction is said to he incompatible. Race specific resistance is strongly correlated with the hypersensitive response (HR) , an induced response by which (it is hypothesized) the plant deprives the pathogen of living host cells by localized cell death at sites of attempted pathogen ingress. It has long been known that HR-associated disease resistance is often (though not exclusively) specified by dominant genes (R genes) . Flor showed that when pathogens mutate to overcome such R genes, these mutations are recessive. Flor concluded that for R genes to function, there must also be corresponding genes in the pathogen, denoted avirulence genes (Avr genes) . To become virulent, pathogens must thus stop making a product that activates R gene-dependent defence mechanisms (Flor, 1971) . A broadly accepted working hypothesis, often termed the elicitor/ receptor model, is that J? genes encode products that enable plants to detect the presence of pathogens, provided said pathogens carry the corresponding Avr gene (Gabriel and Rolfe, 1990) . This recognition is then transduced into the activation of a defence response. Some interactions exhibit different genetic properties. Helminthosporium carbonum races that express a toxin (He toxin) infect maize lines that lack the Hml resistance gene. Mutations to loss of He toxin expression are recessive, and correlated with loss of virulence, in contrast to gene-for-gene interactions in which mutations to virulence are recessive. A major accomplishment was reported in 1992, with the isolation by tagging of the Hml gene- (Johal and Briggs, 1992) . Plausible arguments have been made for how gene-for-gene interactions could evolve from toxin-dependent virulence. For example, plant genes whose products were the target of the toxin might mutate to confer even greater sensitivity to the toxin, leading to HR, and the conversion of a sensitivity gene to a resistance gene. However, this does not seem to be the mode of action of Hml , whose gene product inactivates He toxin. Pathogen avirulence genes are still poorly understood. Several bacterial Avr genes encode hydrophilic proteins with no homology to other classes of protein, while others carry repeating units whose number can he modified to change the range of plants on which they exhibit avirulence (Keen, 1992; Long and Staskawicz, 1993) . Additional bacterial genes (hrp genes) are required for bacterial Avr genes to induce HR, and also for pathogenicity (Keen, 1992; Long and Staskawicz, 1993) . It is not clear why pathogens make products that enable the plant to detect them. It is widely believed that certain easily discarded Avr genes contribute to but are not required for pathogenicity, whereas other Avr genes are less dispensable (Keen, 1992; Long, et al, 1993) . The characterization of two fungal avirulence genes has also been reported. The Avr9 gene of Cladosporium fulvu , which confers avirulence on C. fulvum races that attempt to attack tomato varieties that carry the Cf-9 gene, encodes a secreted cysteine-rich peptide with a final processed size of 28 amino acids but its role in compatible interactions is not clear (De Wit, 1992) . The Avr4 gene of C. fulvum encodes a secreted peptide that is processed to a final size of amino acids 106 (Joosten et al , 1994) The technology for gene isolation based primarily on genetic criteria has improved dramatically in recent years, and many workers are currently attempting to clone a variety of R genes. The map based cloning of the tomato Pto gene that confers "gene-for-gene" resistance to the bacterial speck pathogen Pseudo onas syringae pv tomato (Pst) has been reported (Martin et al , 1993) . A YAC (yeast artificial chromosome) clone was identified that carried restriction fragment length polymorphism (RFLP) markers that were very tightly linked to the gene. This YAC was used to isolate homologous cDNA clones. Two of these cDNAs were fused to a strong promoter, and after transformation of a disease sensitive tomato variety, one of these gene fusions was shown to confer resistance to Pst strains that carry the corresponding avirulence gene, AvrPto . These two cDNAs show homology to each other. Indeed, the Pto cDNA probe reveals a small gene family of at least six members, 5 of which can be found on the YAC from which Pto was isolated, and which thus comprise exactly the kind of local multigene family inferred from genetic analysis of other R gene loci. The Pto gene cDNA sequence is puzzling for proponents of the simple elicitor/receptor model. It reveals unambiguous homology to serine/threonine kinases, consistent with a role in signal transduction. Intriguingly, there is strong homology to the kinases associated with self incompatibility in Brassicas, which carry out an analogous role, in that they are required to prevent the growth of genotypically defined incompatible pollen tubes. However, in contrast to the Brassica SRK kinase (Stein et al , 1991) , the Pto gene appears to code for little more than the kinase catalytic domain and a potential N-terminal myristoylation site that could promote association with membranes. It would be surprising if such a gene product could act alone to accomplish the specific recognition required to initiate the defence response only when the AvrPto gene is detected in invading microorganisms. The race-specific elicitor molecule made by Pst strains that carry AvrPto is still unknown and needs to he characterized before possible recognition of this molecule by the Pto gene product can be investigated. Since the isolation of the Pto gene a number of other resistance genes have been isolated. The isolation of the tobacco mosaic resistance gene N from tobacco was reported by hitham et al (1994) . The isolation of the flax rust resistance gene L6 from flax was reported by Lawrence et al (1995) . The isolation of two Arabidopsis thaliana genes for resistance to Pseudomonas syringae has been reported. The isolation of RPS2 was reported by Bent et al (1994) and by Mindrinos et al (1994) and the isolation of RPM1 was reported by Grant et al (1995) . These genes probably encode cytoplasmic proteins that carry a nucleotide binding site (NBS) and a leucine-rich repeat (LRR) . The ligands with which they interact are uncharacterised and it is not known what other plant proteins they interact with to accomplish the defence response. Our own laboratory has reported the i-solation of the tomato Cf-9 gene which confers resistance against the fungus Cladosporium fulvum. This is disclosed in WO95/18230 and has been reported in Jones et al (1994) . We have also cloned the tomato Cf-2 gene, which confers resistance against Cladosporium fulvum; this is disclosed in an International patent application filed by us on 1 April 1996 claiming priority from GB 9506658.5 filed 31 March 1995 and has been reported in Dixon et al . (1996) . Its structure resembles the Cf-9 gene in that the.DNA sequence predicts a protein which is predominantly extracellular, with many leucine-rich repeats and which carries a C-terminal putative membrane anchor. The Xa21 gene of rice has also been cloned recently (Song et al . , 1995). The predicted protein product of this gene exhibits an N-terminal, presumably extracellular, domain composed principally of leucine rich repeats similar to those of Cf-9 and Cf-2, a predicted transmembrane domain, and a presumably cytoplasmic domain with strong similarities to serine-threonine protein kinases, particularly that encoded by Pto. The subject-matter of the present invention relates to "pathogen resistance genes" or "disease resistance genes" and uses thereof. A pathogen resistance gene (R) enables a plant to detect the presence of a pathogen expressing a corresponding avirulence gene (Avr) . When the pathogen is detected, a defence response such as the hypersensitive response (HR) is activated. By such means a plant may deprive the pathogen of living cells by localised cell death at sites of attempted pathogen ingress. Other genes, including the PGIP gene of W093/11241 (for example) , are induced in the plant defence response resulting from detection of a pathogen by an R gene. A pathogen resistance gene may be envisaged as encoding a receptor to a pathogen-derived and Avr dependent molecule. In this way it may be likened to the RADAR of a plant for detection of a pathogen. Genes involved in the defence the plant mounts to the pathogen once detected are not pathogen resistance genes. Expression of a pathogen resistance gene in a plant causes activation of a defence response in the plant. This may be upon contact of the plant with a pathogen or a corresponding elicitor molecule, though the possibility of causing activation by over- expression of the resistance gene in the absence of elicitor has been reported. The defence response may be activated locally, e.g. at a site of contact of the plant with pathogen or elicitor molecule, or systemically. Activation of a defence response in a plant expressing a pathogen resistance gene may be caused upon contact of the plant with an appropriate, corresponding elicitor molecule. The elicitor may be contained in an extract of a pathogen such as Peronospora parasi tica, or may be wholly or partially purified and may be wholly or partially synthetic. An elicitor molecule may be said to "correspond" if it is a suitable ligand for the R gene product to elicit activation of a defence response. We have now isolated the Arabidopsis RPP5 gene which confers resistance against the downy mildew fungus (Peronospora parasi tica) . We have sequenced the DNA and deduced the most likely amino acid sequence from this gene. The DNA sequence of the Arabidopsis RPP5 genomic gene is shown in Figure 1 (SEQ ID NO. 1) and the deduced amino acid sequence is shown in Figure 2 (SEQ ID NO. 2) . The prediction of the Amino acid sequence is based on the identification of introns by reverse transcriptase polymerase chain reaction using primers designed to the determined genomic sequence. The part of the DNA sequence that is presumed to be spliced into exons and encoding the RPP5 polypeptide is shown in capital letters in Figure 1. Figure 4 (SEQ ID NO 5) shows a contiguous nucleotide sequence coding for the amino acid sequence of Figure 2, made by joining together the exons of the sequence of Figure 1. As described in more detail below, the Arabidopsis RPP5 gene was isolated by map-based cloning. In this technique the locus that confers resistance is mapped at high resolution relative to restriction fragment length polymorphism (RFLP) markers that are linked to the resistance gene. We identified a marker that appeared to be absolutely linked to the resistance gene and used probes corresponding to this marker to isolate binary vector cosmid clones from a library made with DNA of an Arabidopsis landrace Landsberg erecta that carried the RPP5 gene. A binary vector cosmid clone designated 29L17, on transformation into disease sensitive Arabidopsis , conferred disease resistance. DNA sequence analysis of the cloned DNA identified a gene with leucine-rich repeats. A subclone of 29L17, designated pRPP5-l, containing 6304 bp of DNA including 1298 bp 5' to the probable initiation codon (Figure 1) and 458 bp 3' to the probable termination codon was constructed in a binary vector. The subclone was used to transform Arabidopsis ecotype Columbia and shown to confer disease resistance. Analysis of a fast neutron induced mutation of Landsberg that had become disease sensitive revealed rearrangement of the DNA structure of this gene. Taken together these data provide the necessary evidence that the sequences as shown in Figures 1 and 2 correspond to the RPP5 gene. According to one aspect, the present invention provides a nucleic acid isolate encoding a pathogen resistance gene, the gene being characterized in that it encodes the amino acid sequence shown in SEQ ID NO 2, or a fragment thereof, or an amino acid sequence showing a significant degree of homology thereto. N and L6 may be excluded. For instance, embodiments of nucleic acid according to the invention, e.g. encoding a polypeptide comprising an amino acid sequence that is a mutant, derivative, allele or variant of the sequence shown in Figure 2 (as discussed further herein) , may be distinguished from other pathogen resistance genes such as N, L6 by optionally having any one or more of the following features: the encoded polypeptide has less than 30% homology with the amino acid sequence of the tobacco N protein, shown in Figure 3 and less than 25% homology with the amino acid sequence of the flax L6 protein, shown in Figure 3; its expression does not activate said defence response upon contact of the plant with a molecule that is an elicitor of the tobacco N protein; its expression does not activate said defence response upon contact of the plant with a molecule that is an elicitor of the flax L6 protein; its expression does not when in a tobacco plant activate said defence response upon contact of the tobacco plant with Tobacco Mosaic Virus; its expression does not when in a flax plant activate said defence response upon contact of the flax plant with Melampsora lini ; its expression does not activate said defence response upon contact of the plant with a molecule that is an elicitor of the Arabidopsis RPS2 protein; its expression does not activate said defence response upon contact of the plant with a molecule that is an elicitor of the Arabidopsis RPM1 protein; its expression does not when in Arabidopsis thaliana activate said defence response upon contact of the plant with Pseudo onas syringae ; the encoded polypeptide shows less than 20% homology with the amino acid sequence of the tomato Cf-9 protein and less than 20% homology with the amino acid sequence of a tomato Cf-2 protein; its expression does not activate said defence response upon contact of the plant with a molecule that is an elicitor of the tomato Cf-9 protein nor with a molecule that is an elicitor of the tomato Cf-2 protein; its expression does not when in a tomato plant activate said defence response upon contact of the tomato plant with Cladosporium fulvum expressing an Avr2 molecule nor Cladosporium fulvum expressing an Avr9 molecule; the encoded polypeptide comprises a putative nucleotide binding site; the encoded polypeptide is a cytoplasmic protein; the encoded polypeptide comprises a region having homology to the cytoplasmic domain of the Drosophila Toll protein. Another way of distinguishing nucleic acid according to the present invention from other pathogen resistance genes such as N and L6 may be for the encoded polypeptide to comprise an N-terminal domain that has greater than 60% homology with the amino acid sequence of the N-terminal domain of RPP5 shown in Figure 2 (encoded by exon 1 of Figure 1) , and/or comprise a nucleotide binding site domain that has greater than 40% homology with the amino acid sequence of the domain of RPP5 shown in Figure 2 encoded by exon 2 of Figure 1, and/or comprise a domain that has greater than 30% homology with the amino acid sequence of the domain of RPP5 shown in Figure 2 encoded by exon 3 of Figure 1, and/or comprise a domain that has greater than 30% homology with the amino acid sequence of the leucine-rich repeat (LRR) domain of RPP5 shown in Figure 2 encoded by exons 4, 5 and 6 of Figure 1. Table 2 shows % amino acid identity between putative domains of RPP5 and N, and RPP5 and L6, as encoded by exons of the genomic sequences. The nucleic acid may comprise a sequence of nucleotides encoding an amino acid sequence showing at least about 60% homology, preferably at least about 70% homology, at least about 80% homology, or more preferably at least about 90% or greater homology to the amino acid sequence shown in SEQ ID NO 2. Generally, "% amino acid homology" is used to refer to % amino acid identity. High homology may be indicated by ability of complementary nucleic acid to hybridise under appropriate conditions, for instance conditions stringent enough to exclude hybridisation to sequences not encoding a pathogen resistance gene. Thus, the words allele, derivative or mutant may in context be used in respect of any sequence of nucleotides capable of hybridising with any of the nucleotide sequences encoding a polypeptide comprising the relevant sequence of amino acids. Most preferably the nucleic acid encodes the amino acid sequence shown in SEQ ID No 2 in which case the nucleic acid may comprise DNA with an encoding sequence shown in SEQ ID NO 1 or sufficient part to encode the desired polypeptide (eg from the initiating methionine codon to the first in frame downstream stop codon of the mRNA) . In one embodiment, DNA comprises a sequence of nucleotides which are the nucleotides 1966 to 6511 of SEQ ID NO 1, or a mutant, derivative or allele thereof, for instance lacking introns. Figure 4 provides a contiguous sequence encoding the amino acid sequence of Figure 2. A further aspect of the invention provides a nucleic acid isolate encoding a pathogen resistance gene, or a fragment thereof, obtainable by screening a nucleic acid library with a probe comprising nucleotides 1966 to 6511 of SEQ ID NO 1, nucleotides complementary thereto, or a fragment, derivative, mutant or allele thereof, and isolating nucleic acid which encodes a polypeptide able to confer pathogen resistance to a plant. Suitable techniques are well known in the art. Thus, the present invention also provides a method of identifying and/or isolating nucleic acid encoding a pathogen resistance gene comprising probing candidate (or "target") nucleic acid with nucleic acid which has a sequence of nucleotides which encodes the amino acid sequence shown in Figure 2, which is complementary to an encoding sequence or which encodes a fragment of either an encoding sequence or a sequence complementary to an encoding sequence. The candidate nucleic acid (which may be, for instance, cDNA or genomic DNA) may be derived from any cell or organism which may contain or is suspected of containing nucleic acid encoding a pathogen resistance gene. A preferred nucleotide sequence appears in Figure 1. Sequences complementary to the sequence shown, and fragments thereof, may be used. Preferred conditions for probing are those which are stringent enough for there to be a simple pattern with a small number of hybridisations identified as positive which can be investigated further. It is well known in the art to increase stringency of hybridisation gradually until only a few positive clones remain. Nucleic acid according to the present invention may encode the amino acid sequence shown in SEQ ID NO 2 or a mutant, derivative or allele of the sequence provided. Preferred mutants, derivatives and alleles are those which retain a functional characteristic of the protein encoded by the wild-type gene, especially the ability to confer pathogen resistance. Changes to a sequence, to produce a mutant or derivative, may be by one or more of insertion, deletion or substitution of one or more nucleotides in the nucleic acid, leading to the insertion, deletion or substitution of one or more amino acids. Of course, changes to the nucleic acid which make no difference to the encoded amino acid sequence are included. The nucleic acid may be DNA or RNA and may be synthetic, eg with optimised codon usage for expression in a host organism of choice. Nucleic acid molecules and vectors according to the present invention may be provided isolated and/or purified from their natural environment, in substantially pure or homogeneous form, or free or substantially free of nucleic acid or genes of the species of interest or origin other than the sequence encoding a polypeptide with the required function. Nucleic acid according to the present invention may comprise cDNA, RNA, genomic DNA and may be wholly or partially synthetic. The term "isolate" encompasses all these possibilities. Also provided by an aspect of the present invention is nucleic acid comprising a sequence of nucleotides complementary to a nucleotide sequence hybridisable with any encoding sequence provided herein. Another way of looking at this would be for nucleic acid according to this aspect to be hybridisable with a nucleotide sequence complementary to any encoding sequence provided herein. Of course, DNA is generally double-stranded and blotting techniques such as Southern hybridisation are often performed following separation of the strands without a distinction being drawn between which of the strands is hybridising. Preferably the hybridisable nucleic acid or its complement encode a polypeptide able to confer pathogen resistance on a host, i.e. includes a pathogen resistance gene. Preferred conditions for hybridisation are familiar to those skilled in the art, but are generally stringent enough for there to be positive hybridisation between the sequences of interest to the exclusion of other sequences, i.e. sequences not encoding polypeptides able to confer pathogen resistance on a host. The nucleic acid may be in the form of a recombinant vector, for example a phage or cosmid vector. The nucleic acid may be under the control of an appropriate promoter and regulatory elements for expression in a host cell, for example a plant cell. In the case of genomic DNA, this may contain its own promoter and regulatory elements and in the case of cDNA this may be under the control of an appropriate promoter and regulatory elements for expression in the host cell. Those skilled in the art are well able to construct vectors and design protocols for recombinant gene expression. Suitable vectors can be chosen or constructed, containing appropriate regulatory sequences, including promoter sequences, terminator fragments, polyadenylation sequences, enhancer sequences, marker genes and other sequences as appropriate. For further details see, for example, Molecular Cloning: a Laboratory Manual : 2nd edition, Sambrook et al , 1989, Cold Spring Harbor Laboratory Press. Many known techniques and protocols for manipulation of nucleic acid, for example in preparation of nucleic acid constructs, mutagenesis, sequencing, introduction of DNA into cells and gene expression, and analysis of proteins, are described in detail in Short Protocols in Molecular Biology, Second Edition, Ausubel et al. eds., John Wiley & Sons, 1992. The disclosures of Sambrook et al. and Ausubel et al. are incorporated herein by reference. When introducing a chosen gene construct into a cell, certain considerations must be taken into account, well known to those skilled in the art. The nucleic acid to be inserted may be assembled within a construct which contains effective regulatory elements which will drive transcription. There must be available a method of transporting the construct into the cell. Once the construct is within the cell membrane, integration into the endogenous chromosomal material may or may not occur according to different embodiments of the invention. Finally, as far as plants are concerned the target cell type must be such that cells can be regenerated into whole plants. Plants transformed with a DNA segment containing pre-sequence may be produced by standard techniques which are already known for the genetic manipulation of plants. DNA can be transformed into plant cells using any suitable technology, such as a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP-A-270355, EP-A-0116718, NAR 12(22) 8711 - 87215 1984), particle or microprojectile bombardment (US 5100792, EP-A-444882, EP-A-434616). microinjection (WO 92/09696, WO 94/00583, EP 331083, EP 175966), electroporation (EP 290395, WO 8706614) or other forms of direct DNA uptake (DE 4005152, WO 9012096, US 4684611) . Agrobacterium transformation is widely used by those skilled in the art to transform dicotyledonous species. Although Agrobacterium has been reported to be able to transform foreign DNA into some monocotyledonous species (WO 92/14828) , microprojectile bombardment, electroporation and direct DNA uptake are preferred where Agrobacterium is inefficient or ineffective. Alternatively, a combination of different techniques may be employed to enhance the efficiency of the transformation process, eg. bombardment with Agrobacterium coated microparticles (EP-A-486234) or microprojectile bombardment to induce wounding followed by co-cultivation with Agrobacterium (EP-A-486233) . The particular choice of a transformation technology will be determined by its efficiency to transform certain plant species as well as the experience and preference of the person practising the invention with a particular methodology of choice. It will be apparent to the skilled person that the particular choice of a transformation system to introduce nucleic acid into plant cells is not essential to or a limitation of the invention. The RPP5 gene, modified versions thereof and related genes encoding a protein showing a significant degree of homology to the protein product of the RPP5 gene, alleles, mutants and derivatives thereof, may be used to confer pathogen resistance, e.g. to downy mildews, in plants. For this purpose nucleic acid as described above may be used for the production of a transgenic plant. Such a plant may possess pathogen resistance conferred by the RPP5 gene. The invention thus further encompasses a host cell transformed with a vector as disclosed, especially a plant or a microbial cell. Thus, a host cell, such as a plant cell, comprising nucleic acid according to the present invention is provided. Within the cell, the nucleic acid may be incorporated within the chromosome. A vector comprising nucleic acid according to the present invention need not include a promoter, particularly if the vector is to be used to introduce the nucleic acid into cells for recombination into the genome. Also according to the invention there is provided a plant cell having incorporated into its genome a sequence of nucleotides as provided by the present invention, under operative control of a promoter for control of expression of the encoded polypeptide. A further aspect of the present invention provides a method of making such a plant cell involving introduction of a vector comprising the sequence of nucleotides into a plant cell. Such introduction may be followed by recombination between the vector and the plant cell genome to introduce the sequence of nucleotides into the genome. The polypeptide encoded by the introduced nucleic acid may then be expressed. A plant which comprises a plant cell according to the invention is also provided, along with any clone of such a plant, seed, selfed or hybrid progeny and descendants, and any part of any of these, such as cuttings, seed. The invention provides any plant propagule, that is any part which may be used in reproduction or propagation, sexual or asexual, including cuttings, seed and so on. The invention further provides a method comprising expression from nucleic acid encoding the amino acid sequence SEQ ID NO 2, or a mutant, allele or derivative thereof, or a significantly homologous amino acid sequence, within cells of a plant (thereby producing the encoded polypeptide) , following an earlier step of introduction of the nucleic acid into a cell of the plant or an ancestor thereof. Such a method may confer pathogen resistance on the plant. A gene stably incorporated into the genome of a plant is passed from generation to generation to descendants of the plant, cells of which descendants may express the encoded polypeptide and so may have enhanced pathogen resistance. Pathogen resistance may be determined by assessing compatibility of a pathogen such as Peronospora parasi tica or Bremia lactucae . Sequencing of the RPP5 gene has shown that like the Cf-9 gene and the Cf-2 gene it includes DNA sequence encoding leucine-rich repeat (LRR) regions and homology searching has revealed strong homologies to other genes containing LRRs. As discussed in WO95/18230, and further validated in this discovery, the presence of LRRs may be characteristic of many pathogen resistance genes and the presence of LRRs can thus be used in a method of identifying further pathogen resistance genes. Furthermore, there are some striking homologies between RPP5 and the tobacco mosaic virus resistance gene N and the flax rust resistance gene L6. (Figure 3) . (As can be derived from Figure 3, the overall homology between RPP5 and Ν is 33% amino acid identity, while the figure for RPP5 and L6 is 27%.) These homologies may also be used to identify further resistance genes, for example using oligonucleotides (e.g. a degenerate pool) designed on the basis of sequence conservation, preferably conservation of amino acid sequence. In particular, primers may be designed that amplify DΝA between the regions of the gene that encode the amino acid sequence F Y D V D P (SEQ ID NO 6) of RPP5 and N and where in L6 it encodes F Y M V D P (SEQ ID NO 7) , and the region I A C F F (SEQ ID NO 8) of RPP5 , where the sequence is identical in Lβ and in N is I A C F L (SEQ ID NO 9) . According to a further aspect, the present invention provides a method of identifying a plant pathogen resistance gene comprising use of an oligonucleotide(s) which comprise(s) a sequence or sequences that are conserved between pathogen resistance genes such as RPP5, N and L6 to search for new resistance genes. Thus, a method of obtaining nucleic acid comprising a pathogen resistance gene (encoding a polypeptide able to confer pathogen resistance) is provided, comprising hybridisation of an oligonucleotide (details of which are discussed herein) or a nucleic acid molecule comprising such an oligonucleotide to target/candidate nucleic acid. Target or candidate nucleic acid may, for example, comprise a genomic or cDNA library obtainable from an organism known to encode a pathogen resistance gene. Successful hybridisation may be identified and target/candidate nucleic acid isolated for further investigation and/or use. Hybridisation may involve probing nucleic acid and identifying positive hybridisation under suitably stringent conditions (in accordance with known techniques) and/or use of oligonucleotides as primers in a method of nucleic acid amplification, such as PCR. For probing, preferred conditions are those which are stringent enough for there to be a simple pattern with a small number of hybridisations identified as positive which can be investigated further. It is well known in the art to increase stringency of hybridisation gradually until only a few positive clones remain. As an alternative to probing, though still employing nucleic acid hybridisation, oligonucleotides designed to amplify DNA sequences may be used in PCR reactions or other methods involving amplification of nucleic acid, using routine procedures. See for instance "PCR protocols; A Guide to Methods and Applications", Eds. Innis et al , 1990, Academic Press, New York. Preferred amino acid sequences suitable for use in the design of probes or PCR primers are sequences conserved (completely, substantially or partly) between at least two polypeptides able to confer pathogen resistance such as those encoded by RPP5 and N and/or L6. On the basis of amino acid sequence information oligonucleotide probes or primers may be designed, taking into account the degeneracy of the genetic code, and, where appropriate, codon usage of the organism from the candidate nucleic acid is derived. Preferred nucleotide sequences may include those comprising or having a sequence encoding amino acids (i) F Y D V D P (SEQ ID NO 6) ; (ii) I A C F F (SEQ ID NO 8) or a sequence complementary to these encoding sequences. Suitable fragments of these may be employed. For example, the oligonucleotide TTC/T TAC/T GAC/T GTX GAT/C CC (SEQ ID NO 10) can be derived from the amino acid sequence F Y D V D P. Such an oligonucleotide primer could be used in PCR in combination with the primer A A G/A AA G/A CA XGC T/G/A AT (SEQ ID NO 11) , derived from the bottom strand of the sequence that encodes I A C F F. (All sequences given 5' to 3' ; see Figure 3) . X indicates A, G, C or T. Preferably an oligonucleotide in accordance with the invention, e.g. for use in nucleic acid amplification, has about 10 or fewer codons (e.g. 6, 7 or 8) , i.e. is about 30 or fewer nucleotides in length (e.g. 18, 21 or 24) . Assessment of whether or not such a PCR product corresponds to resistance genes may be conducted in various ways. A PCR band from such a reaction might contain a complex mix of products. Individual products may be cloned and each one individually screened for linkage to known disease resistance genes that are segregating in progeny that showed a polymorphism for this probe. Alternatively, the PCR product may be treated in a way that enables one to display the polymorphism on a denaturing polyacrylamide gel and specific bands that are linked to the resistance gene may be preselected prior to cloning. Once a candidate PCR band has been cloned and shown to be linked to a known resistance gene, it may then be used to isolate cDNA clones which may be inspected for other features and homologies to either RPP5, N or L6. It may subsequently be analysed by transformation to assess its function on introduction into a disease sensitive variety of the plant of interest. Alternatively, the PCR band or sequences derived by analysing it may be used to assist plant breeders in monitoring the segregation of a useful resistance gene. A further method of using the RPP5 sequence to identify other resistance genes is to use computer searches of expressed sequence tag (EST) and other DNA sequence databases to identify genes in other species that encode proteins with significant RPP5 homology. For example, a homology score of at least 60 using one of the BLAST algorithms (Altschul et al , 1990) would indicate a candidate resistance gene. Having obtained nucleic acid using any of these approaches, a nucleic acid molecule comprising ..all or part of the sequence of the obtained nucleic acid may be used in the production of a transgenic plant, for example in order to confer pathogen resistance on the plant. Modifications to the above aspects and embodiments and further aspects and embodiments of the present invention will be apparent to those skilled in the art. All documents cited are incorporated herein by reference. Figure 1 shows the genomic DNA sequence of the RPP5 gene (SEQ ID NO. 1) . Introns are shown in this Figure in non-capitalised letters. Features: Nucleic acid sequence - Translation start at nucleotide 1966; translation stop at nucleotide 6512. Figure 2 shows predicted RPP5 protein amino acid sequence (SEQ ID NO 2) . Figure 3 shows a comparison of the predicted amino acid sequence of the RPP5 (SEQ ID NO 2), N (SEQ ID NO 3) and L6 (SEQ ID NO 4) genes. The protein sequences are aligned according to predicted protein domains. Figure 3 was produced using the PRETTYBOX and PileUp programs of the University of Wisconsin Genetics Computer Group Sequence Analysis Software Package Version 7.2. Figure 4 shows a contiguous nucleotide sequence (SEQ ID NO 5) encoding the amino acid sequence-.shown in Figure 2 (SEQ ID NO 2) , and made by joining together the sequences of the exons of the sequence of Figure 1 (SEQ ID NO 1) . Cloning of the Arabidopsis RPP5 gene The RPP5 gene was cloned using a map-based cloning strategy similar in principle to that used for the isolation of the tomato Pto gene, described briefly earlier. (i ) Assignment of RPP5 gene map locations The map location of RPP5 on the Arabidopsis RFLP map has been reported earlier (Parker et al , 1993) . This paper describes in detail how two landraces of Arabidopsis, designated Columbia and Landsberg erecta, showed a differential response to a race of Peronospora parasi tica designated NoCo-2; Landsberg erecta is resistant, and Columbia is sensitive. Recombinant inbred lines (Lister and Dean, 1993) had been constructed, derived from carrying out single seed descent on F2 seed derived from an FI between Landsberg and Columbia, and these recombinant inbred lines were tested for resistance or sensitivity to NoCo-2. This analysis showed that the RPP5 gene lay on Chromosome 4 between the RFLP markers m226 and g4539. The DNA of Landsberg and Columbia was analysed using the RAPD (randomly amplified polymorphic DNA) technique (Williams et al , 1990) and polymorphisms between Landsberg and Columbia were analysed for linkage to RPP5. One polymorphism derived using the operon primer OPC18, which amplified a band in Columbia but not in Landsberg was absolutely linked to RPP5. This DNA band, of 540 bp (referred to as OPC18 540 in Parker et al . , 1993) was cloned and the resulting probe was designated the C18 probe. (ii ) Establishment of a physical map between marker m226 and marker g4539 The Arabidopsis genome project has as an objective the establishment of a physical map of Chromosome 4, and ultimately of the entire Arabidopsis genome. The C18 probe was used to identify hybridising yeast artificial chromosome (YAC) clones. This facilitated the establishment of a physical contig between 4539 and 226 incorporating other linked markers, such as gl3683. The C18 RAPD band was cloned and used as a probe on Columbia and Landsberg genomic DNA. Hybridisation of this probe revealed a very polymorphic small multi-gene family in these two genotypes. Hybridisation to recombinant inbred lines (Lister and Dean, 1993) showed that all members of this multi-gene family were absolutely linked to the resistance gene locus. Using the CAPS procedure (Konieczny and Ausubel, 1993) the individuals in an F2 population derived from selfing an Fl of a Columbia and Landsberg cross were screened for recombinants between the linked markers Ara-1 and 4539. The primers used for the Ara-1 locus were Ara-1 5' TCG ACG ACT CTC AAG AAC CC 3' Ara-2 5' CAC AAG CTA TAC GAT GCT CAC C 3' This gave a 700 bp band in Columbia and Landsberg which, after digestion with Acc-1, cut Landsberg DNA giving a 360 bp and a 340 bp band. The primers used for the 4539 locus were 4539 F 5' GGT CAT CCG TTC CCA GGT AAA G 3' 4539 R 5' GGA CGT AGA ATC TGA GAG CTC 3' After Hind III digestion, the Columbia 600 bp band remained uncut, whilst the Landsberg band was cut to give 480 bp and 120 bp fragments. In this way twenty- four additional recombinants were derived in this interval. Analysis of these recombinants showed that again all members of the C18 multi-gene family co- segregated exactly with RPP5. Since linked multi-gene families are a characteristic of disease resistance genes (Martin et al , 1993; Jones et al , 1994; Whitham et al , 1994) we tested the hypothesis that the C18 band might hybridise to the RPP5 gene. Cosmids were identified from a Landsberg binary vector cosmid library in the vector pCLD04541 (C. Dean, pers. com.; Bent et al , 1994) and cosmid clones that hybridised to the C18 probe were identified. Table 1 lists the hybridising clones. Each of these were used in transformation experiments with the readily transformable Arabidopsis landrace, No-O,which is sensitive to NoCO-2. A transformant was identified derived from transformation with cosmid 29L17, and self-progeny of this transformant segregated for resistance to P. parasi tica NoCO-2. This demonstrated that the clone 29L17, which carries a band that hybridises to the C18 RAPD probe, carries a functional Peronospora parasi tica resistance gene. ■ (iii) DNA sequence analysis of the 29L11 plant DNA insert Cosmid DNA was prepared from 29L17, sonicated and cloned into pUC18 vector and randomly sequenced. Two hundred and forty (240) DNA sequencing reactions were performed on random clones that were identified as clones that hybridised to 29L17 insert DNA, i.e. clones that carried inserts of plant DNA. From a computer analysis of this DNA sequence data, a DNA sequence contig could be established comprising 14.3 kb of DNA. This DNA sequence was inspected for the presence of sequences that encoded leucine-rich repeats. One such region, nucleotide 3000 to nucleotide 6138 in SEQ ID NO. 1, was found. (iv) Analysis of a DNA rearrangement associated with an RPP5 mutation One criterion for establishing whether or not a characterised region of plant DNA corresponds to the gene of interest is to inspect whether mutations in the corresponding gene, caused by ionizing radiation, are associated with DNA rearrangements in the region of interest. Fast neutron mutagenised Landsberg seed were screened with Peronospora parasi tica for mutants to disease sensitivity. Three mutations were found and analysed by Southern blots for perturbations or rearrangements in DNA corresponding to the gene, carrying leucine rich repeats. One mutant line, FNB387, showed an altered pattern of Southern blot hybridisation. More detailed analysis showed that the perturbation consists of an insertion of 270 bp of DNA in the C-terminus of the reading frame that carries leucine-rich repeats. Sequence analysis of this region showed that an insertion of 270 bp had arisen from the duplication of several LRRs within the gene carried on cosmid 29L17. This provides very strong evidence that the RPP5 gene corresponds to the reading frame that carries leucine-rich repeats. (v) Demonstration that a subclone of 29L11 contains RPP5 To confirm that the gene identified by mutagenesis is not only necessary but also sufficient to confer disease resistance, a subclone of 29L17 was constructed in binary vector SLJ7292. The subclone, designated pRPP5-l, contained a 6304 bp DNA fragment defined by a Bglll restriction enzyme site 5' to the gene (nucleotide 668 in SEQ ID NO. 1) and a PstI restriction enzyme site 3' to the gene (nucleotide 6971 in SEQ ID NO. 1) . pRPP5-l was used to transform Arabidopsis ecotype Columbia and shown to confer disease resistance. (vi ) RT-PCR analysis of the RPP5 transcript First strand cDNA was prepared from seedling leaf messenger RNA and PCR amplification from this cDNA was performed using intron flanking primers. The primers were: for intron 1, 5' -GAGTTCGCTCTATCATCTCC and 5< -TTATTGCATTCGAAACATCATTG; for introns 2 and 3, 5' -AAATTGATCGTGCAAAGTCC and 5' -AAGATTCGCATTCTTCAAGATT; for intron 4, 5' -GAAGATGGATTTGTATAATTCC and 5' -TCAAATTCGGGCATCCAGTG. For intron 5 a nested PCR strategy was employed, an aliquot of the products of the first amplification being used as the template for the second. The primers used were: for the first amplification, 5' -TGGTGACACTTCCTTCCTCG and 5' -CCAAACTTTTGCAGTTGTTG; for the second amplification 5' -TCTCAATGTGAGCGGCTGCAAGC and 5' -AACTTGAGCAACCACTGAGATCG. Cloned PCR products were sequenced using a combination of vector-specific and insert-specific primers. Intron sequences are shown in lower case in SEQ ID NO. 1 (Figure 1) between the exon sequences shown in upper case. (vii) Comparison of the RPP5 gene sequence wi th the sequences of other resistance genes Comparison of the RPP5 sequence to the genes N and L6 reveals very strong homologies throughout the N- terminal region. These regions are highlighted in Figure 3. They include regions involved in nucleotide binding, designated Kinase-la, Kinase-2, Kinase-3a. Kinase-la is often referred to as the P-loop. Also, regions Ν-terminal to the nucleotide binding domain show conspicuous homologies. Primers were designed particularly to the conserved regions carrying the amino acid sequence F Y D V D P (amino acids 104 to 109 of RPP5) and to amino acids I A C F F (437-441 of RPP5) . When degenerate oligonucleotide primers based on amino acid sequence were used in PCR reactions, both on Arabidopsis genomic DΝA and on cDΝA made from RΝA of other species, products were observed of the size consistent with the potential to encode resistance genes. These primers could alone, or in combination with other primers encoding conserved and non-conserved regions of the identified resistance genes, be used to isolate other homologous gene sequences which could include previously uncharacterized resistance genes. Table 1 : Binary vector cosmid clones hybridising to C18 Binary vector: 04541 Transformed into No-o 3D23 27E2 29L17 38G10 42P15 Subsequently identified: 45F8 18A10 56G2 Table 2 : % amino acid identity between RPP5 and N; RPP5 and L6 N exonl N exon 2 N exon 3 N exon 4+5 RPP5 exon 1 55 exon 2 36 exon 3 26 exon 4,5+6 26 L6 exon 1 L6 exon 2 L6 exon 3 L6 exon 4 RPP5 exon 1 37 exon 2 30 exon 3 17 exon 4,5+6 26 REFERENCES I. Bent AF, et al. , (1994) . RPS2 of Arabidopsis thaliana : Science 265:1856. 2. De Wit PJGM (1992) . Ann.Rev.Phytopathol. 30:391-418. 3. Dixon, MD, et al. (1996) Cell 84:451-459. 4. Flor HH (1971) . Ann.Rev.Phytopathol. 9:275-296. 5. Gabriel DW, et al. , (1990) . Ann.Rev.Phytopathol . 28:365-391. 6. Grant, MR, et al. Science 269: 843-846 (1995) 7. Johal GS, et al. , (1992) . Science (Wash.) . 258:985-987. 8. Jones DA, et al. , (1994) . Science 266:789-793. 9. Joosten MHAJ, et al. , (1994) . Nature 367:384. 10. Keen NT, (1992) . Ann.Re .Gen. 24:447-463. II. Konieczny A, et al. , (1993) . Plant Journal 4:403-407. 12. Lawrence, GJ et al. Plant Cell 7: 1195-1206 (1995) 13. Lister C, et al. , (1993) . Plant Journal (in press) . 14. Long SR, et al. , (1993) . Cell 73:921-935. 15. Martin GB, et al. , (1993) . Science 262:1432-1436. 16. Mindrinos M, et al. , (1994) . Cell 78:1089-1099. 17. Parker JE, et al. , (1993) . Plant Journal 4:821-831. 18. Song W-Y, et al . (1995) . Science 270: 1804-1806. 19. Stein JC, et al. , (1991) . Proc.Natl.Acad.Sci.USA. 88:8816-8820. 20. Whitham S, et al. , (1994) . Cell 78:1011-1115. 21. Williams JGK, et al. , (1991) . Nucl.Acids Res. 18:6531-6535. 22. Altschul, S.F., et al., (1990) . J. Mol. Biol. 215:403-410.

Claims: CLAIMS 1. A nucleic acid isolate encoding a pathogen resistance gene whose expression in a plant can cause activation of a defence response in the plant, comprising a sequence of nucleotides encoding a polypeptide comprising the sequence of amino acids shown in Figure 2 2. Nucleic acid according to claim 1 wherein said activation is upon contact of the plant with a pathogen or corresponding elicitor molecule. 3. Nucleic acid according to claim 1 wherein the sequence of nucleotides comprises an encoding sequence shown in Figure 1. 4. Nucleic acid according to claim 1 wherein the sequence of nucleotides comprises an allele, derivative or mutant, by way of addition, insertion, deletion or substitution of one or more nucleotides, of an encoding sequence shown in Figure 1. 5. Nucleic acid encoding a pathogen resistance gene whose expression in a plant can cause activation of a defence response in the plant, comprising a sequence of nucleotides encoding a polypeptide, the polypeptide comprising an amino acid sequence which comprises an allele, derivative or mutant, by way of addition, insertion, deletion or substitution of one or more amino acids, of the amino acid sequence shown in Figure 2; with the proviso that the encoded polypeptide has at least about 60% homology with the amino acid sequence shown in Figure 2. 6. Nucleic acid encoding a pathogen resistance gene whose expression in a plant can cause activation of a defence response in the plant, comprising a sequence of nucleotides encoding a polypeptide, the polypeptide comprising an amino acid sequence which comprises an allele, derivative or mutant, by way of addition, insertion, deletion or substitution of one or more amino acids, of the amino acid sequence shown in Figure 2; with the proviso that expression of the nucleic acid can cause said activation of a defence response upon contact of the plant with an Oomycete fungus, such as Peronospora parasi tica , or an extract thereof. 7. Nucleic acid according to claim 5 or claim 6 wherein said activation is upon contact of the plant with a pathogen or corresponding elicitor molecule. 8. Nucleic acid which is a vector comprising nucleic acid according to any one of claims 1 to 7. 9. Nucleic acid according to claim 8 further comprising regulatory sequences for expression of said polypeptide. 10. Use of nucleic acid according to any one of the precedings claims in production of a transgenic plant. 11. A host cell comprising nucleic acid according to any one of claims 1 to 9. 12. A host cell according to claim 11 which is microbial. 13. A host cell according to claim 11 which is a plant cell. 14. A plant or any part thereof comprising a cell according to claim 13. 15. Seed, selfed or hybrid progeny or a descendant or derivative or extract of a plant according to claim 14, or any part thereof. 16. A method which comprises introduction of nucleic acid according to any one of claims 1 to 9 into a host cell. 17. A method according to claim 16 wherein the host cell is a plant or microbial cell. 18. A method of conferring pathogen resistance on a plant, comprising expression from nucleic acid according to any one of claims 1 to 9, within cells of the plant, following an earlier step of introduction of the nucleic acid into a cell of the plant or an ancestor thereof. 19. A method according to claim 18 wherein the nucleic acid encodes an amino acid sequence shown in Figure 2. 20. An oligonucleotide comprising a sequence encoding an amino acid sequence conserved between RPP5 of Arabidopsis and another pathogen resistance genes or comprising a sequence complementary to a nucleotide sequence encoding a said amino acid sequence. 21. An oligonucleotide according to claim 20 wherein the pathogen resistance gene is N of tobacco or L6 of flax. 22. An oligonucleotide according to claim 21 comprising a nucleotide sequence encoding one of the amino acid sequences: (i) F Y D/M V D P; and ( ii) I A C F F/L or comprising a nucleotide sequence complementary to a said encoding sequence. 23. An oligonucleotide according to claim 22 comprising a sequence selected from: (i) T T C/T T A C/T G A C/T G T X G A T/C C C; (ii) A A G/A A A G/A C A X G C T/G/A A T; and (iii) a sequence complementary to (i) or (ii) . 24. An oligonucleotide which comprises a sequence which is a variant or derivative, by way of addition, insertion, deletion or substitution of one or more nucleotides, of the sequence of an oligonucleotide according to any one of claims 20 to 23. 25. A method of obtaining nucleic acid comprising a pathogen resistance gene comprising hybridisation of an oligonucleotide according to any one of claims 20 to 24, or a nucleic acid molecule comprising a said oligonucleotide, to target nucleic acid. 26. A method according to claim 25 involving use of nucleic acid amplification. 27. A method according to claim 25 or claim 26 wherein the hybridisation is followed by identification of successful hybridisation and isolation of target nucleic acid. 28. A method wherein following the obtaining of nucleic acid using the method of any of claims 25 to 27 a nucleic acid molecule comprising all or part of the sequence of the obtained nucleic acid is used in the production of a transgenic plant. 29. A method according to claim 28 wherein said nucleic acid molecule is used to confer pathogen resistance on said plant.

Inventors: COLEMAN MARK, DANIELS MICHAEL JOHN, JONES JONATHAN DALLAS GEORGE, PARKER JANE, SZABO VERONIQUE, COLEMAN, MARK, DANIELS, MICHAEL, JOHN, JONES, JONATHAN, DALLAS, GEORGE, PARKER, JANE, SZABO, VERONIQUE;
Applicants: COLEMAN MARK, DANIELS MICHAEL JOHN, INNES JOHN CENTRE INNOV LTD, JONES JONATHAN DALLAS GEORGE, PARKER JANE, SZABO VERONIQUE, COLEMAN, MARK, DANIELS, MICHAEL, JOHN, JOHN INNES CENTRE INNOVATIONS LIMITED, JONES, JONATHAN, DALLAS, GEORGE, PARKER, JANE, SZABO, VERONIQUE;
Application year: 1996
Main classification: C12N15
IPC codes: A01H1, A01H5, C07K14, C12N1, C12N5, C12N15, C12Q1, C12R1